M42 Health
United Arab Emirates
26th June 2025
2506-1956-16
Overview
M42’s Integrated Health Solutions (IHS) platform drives transformative national programs and population health initiatives, addressing global health challenges through precision, prevention, and predictive care. Flagship initiatives include the Emirati Genome Program (EGP), which maps Emirati genetics to enable personalized and preventive healthcare; the Abu Dhabi BioBank, a regional center accelerating drug discovery and biobanking excellence; and Biogenix Labs, which advances precision medicine through Next-Generation Sequencing (NGS) technologies. Environmental Sciences complements these efforts by analyzing non-human factors affecting public health. IROS (Integrated Research Organization Solutions) supports innovation through high-quality clinical research, reinforcing M42’s commitment to a healthier, more sustainable future.
As a Senior Associate, Strategy, you will play a key role in identifying new opportunities, developing robust business cases, and shaping the strategic direction of IHS. You will collaborate with cross-functional teams, conduct in-depth market and financial analysis, and support leadership in decision-making for high-impact initiatives.
Responsibilities
Role Level: | Mid-Level | Work Type: | Full-Time |
---|---|---|---|
Country: | United Arab Emirates | City: | Abu Dhabi |
Company Website: | https://m42.ae/ | Job Function: | Strategy & Planning |
Company Industry/ Sector: |
Hospitals and Health Care |
M42 is an Abu Dhabi-based, global tech-enabled healthcare company operating at the forefront of medical advancement. The company is seeking to transform lives through innovative clinical solutions that can solve the world’s most critical health and diagnostic challenges. By harnessing unique medical and data-centric technologies, including genomics and AI, M42 is transforming the traditional healthcare ecosystem and delivering the highest level of precise, patient-centric, and preventative care.M42 has over 20,000 employees and more than 450 facilities in 26 countries around the world. M42 owns a wide portfolio of assets that includes Amana Healthcare, Biogenix Labs, Danat Al Emarat, Diaverum, HealthPoint Hospital, the HealthPlus network of specialty centers, Moorfields Eye Hospital Abu Dhabi, Imperial College London Diabetes Centre, Insights Research Organization & Solutions (IROS), Omics Center of Excellence and National Reference Laboratory, among others.
Disclaimer: talentmate.com is only a platform to bring jobseekers & employers together. Applicants are advised to research the bonafides of the prospective employer independently. We do NOT endorse any requests for money payments and strictly advice against sharing personal or bank related information. We also recommend you visit Security Advice for more information. If you suspect any fraud or malpractice, email us at abuse@talentmate.com.